

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tryptophan catabolic process (GO:0006569) | 5.34085888 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 5.34085888 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 5.34085888 |
| 4 | kynurenine metabolic process (GO:0070189) | 4.91993080 |
| 5 | indolalkylamine metabolic process (GO:0006586) | 4.79328193 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.78513518 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.78513518 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.78513518 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.78513518 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.78513518 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.78513518 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72920016 |
| 13 | tryptophan metabolic process (GO:0006568) | 4.56141216 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.47728354 |
| 15 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.43392278 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33784750 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.27416372 |
| 18 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.21636978 |
| 19 | positive regulation of developmental pigmentation (GO:0048087) | 4.13883760 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.06368563 |
| 21 | regulation of pigment cell differentiation (GO:0050932) | 4.01519092 |
| 22 | protein K11-linked deubiquitination (GO:0035871) | 3.99080415 |
| 23 | regulation of hippo signaling (GO:0035330) | 3.98493838 |
| 24 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.97731967 |
| 25 | interkinetic nuclear migration (GO:0022027) | 3.87258045 |
| 26 | snRNA transcription (GO:0009301) | 3.84421771 |
| 27 | protein K48-linked deubiquitination (GO:0071108) | 3.82130612 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81809492 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81809492 |
| 30 | establishment of protein localization to Golgi (GO:0072600) | 3.75568733 |
| 31 | neural tube formation (GO:0001841) | 3.74191027 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.74051260 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.64884812 |
| 34 | regulation of establishment of cell polarity (GO:2000114) | 3.64061356 |
| 35 | response to peptidoglycan (GO:0032494) | 3.60618355 |
| 36 | indole-containing compound metabolic process (GO:0042430) | 3.56105799 |
| 37 | lipid translocation (GO:0034204) | 3.53841024 |
| 38 | phospholipid translocation (GO:0045332) | 3.53841024 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.52763683 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.49518821 |
| 41 | detection of light stimulus involved in visual perception (GO:0050908) | 3.49518821 |
| 42 | fucose catabolic process (GO:0019317) | 3.49328406 |
| 43 | L-fucose metabolic process (GO:0042354) | 3.49328406 |
| 44 | L-fucose catabolic process (GO:0042355) | 3.49328406 |
| 45 | behavioral response to nicotine (GO:0035095) | 3.49253051 |
| 46 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.47202448 |
| 47 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.47202448 |
| 48 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.47202448 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45075997 |
| 50 | cellular response to ethanol (GO:0071361) | 3.44163209 |
| 51 | respiratory burst (GO:0045730) | 3.35882973 |
| 52 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.26043807 |
| 53 | NAD biosynthetic process (GO:0009435) | 3.24689673 |
| 54 | response to host immune response (GO:0052572) | 3.24133004 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24133004 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 3.22773499 |
| 57 | regulation of gene silencing by RNA (GO:0060966) | 3.21829766 |
| 58 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.21829766 |
| 59 | regulation of gene silencing by miRNA (GO:0060964) | 3.21829766 |
| 60 | reflex (GO:0060004) | 3.21026499 |
| 61 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.19523362 |
| 62 | positive regulation of interferon-beta production (GO:0032728) | 3.17406151 |
| 63 | photoreceptor cell maintenance (GO:0045494) | 3.16461791 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 3.15045661 |
| 65 | amine catabolic process (GO:0009310) | 3.15045661 |
| 66 | thyroid hormone metabolic process (GO:0042403) | 3.15031931 |
| 67 | protein K63-linked deubiquitination (GO:0070536) | 3.14036234 |
| 68 | low-density lipoprotein particle clearance (GO:0034383) | 3.11318977 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09992100 |
| 70 | oxidative demethylation (GO:0070989) | 3.06710210 |
| 71 | regulation of sarcomere organization (GO:0060297) | 3.04931885 |
| 72 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.02625483 |
| 73 | granulocyte activation (GO:0036230) | 3.01661627 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.01283285 |
| 75 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00896795 |
| 76 | cellular response to sterol (GO:0036315) | 3.00212350 |
| 77 | serotonin metabolic process (GO:0042428) | 3.00070589 |
| 78 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.99922830 |
| 79 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.99635543 |
| 80 | gamma-aminobutyric acid transport (GO:0015812) | 2.98642511 |
| 81 | response to pheromone (GO:0019236) | 2.97680940 |
| 82 | negative regulation of sodium ion transport (GO:0010766) | 2.96151636 |
| 83 | sulfation (GO:0051923) | 2.95956620 |
| 84 | B cell mediated immunity (GO:0019724) | 2.95250021 |
| 85 | neutrophil activation (GO:0042119) | 2.92295038 |
| 86 | response to interferon-alpha (GO:0035455) | 2.91617771 |
| 87 | natural killer cell mediated immunity (GO:0002228) | 2.90994752 |
| 88 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.90994752 |
| 89 | primary amino compound metabolic process (GO:1901160) | 2.90538747 |
| 90 | ketone body metabolic process (GO:1902224) | 2.90200574 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89832421 |
| 92 | response to host (GO:0075136) | 2.89832421 |
| 93 | response to host defenses (GO:0052200) | 2.89832421 |
| 94 | response to type I interferon (GO:0034340) | 2.89331431 |
| 95 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88769780 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.88271404 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.88271404 |
| 98 | flavonoid metabolic process (GO:0009812) | 2.88222969 |
| 99 | regulation of cholesterol storage (GO:0010885) | 2.86169659 |
| 100 | reactive oxygen species biosynthetic process (GO:1903409) | 2.84453155 |
| 101 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.83879739 |
| 102 | pericardium development (GO:0060039) | 2.83760772 |
| 103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81423194 |
| 104 | protein targeting to lysosome (GO:0006622) | 2.79208180 |
| 105 | establishment of protein localization to vacuole (GO:0072666) | 2.79208180 |
| 106 | protein targeting to vacuole (GO:0006623) | 2.79208180 |
| 107 | aromatic amino acid family catabolic process (GO:0009074) | 2.78469894 |
| 108 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.78083456 |
| 109 | cAMP catabolic process (GO:0006198) | 2.77844938 |
| 110 | auditory receptor cell stereocilium organization (GO:0060088) | 2.77752768 |
| 111 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.75169735 |
| 112 | negative regulation of mast cell activation (GO:0033004) | 2.74029078 |
| 113 | leukocyte aggregation (GO:0070486) | 2.73397960 |
| 114 | pinocytosis (GO:0006907) | 2.71865073 |
| 115 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.71041992 |
| 116 | regulation of chemokine biosynthetic process (GO:0045073) | 2.69814869 |
| 117 | myeloid cell activation involved in immune response (GO:0002275) | 2.69689733 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 2.69181718 |
| 119 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67509412 |
| 120 | inner ear receptor stereocilium organization (GO:0060122) | 2.65237079 |
| 121 | cellular extravasation (GO:0045123) | 2.65151597 |
| 122 | negative regulation of lipid storage (GO:0010888) | 2.64959822 |
| 123 | response to muramyl dipeptide (GO:0032495) | 2.64281158 |
| 124 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63429208 |
| 125 | cyclic nucleotide catabolic process (GO:0009214) | 2.61529616 |
| 126 | cellular response to ATP (GO:0071318) | 2.61358037 |
| 127 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57788709 |
| 128 | proline transport (GO:0015824) | 2.57248760 |
| 129 | negative regulation of neurotransmitter transport (GO:0051589) | 2.56847391 |
| 130 | central nervous system neuron axonogenesis (GO:0021955) | 2.56803603 |
| 131 | tachykinin receptor signaling pathway (GO:0007217) | 2.56611816 |
| 132 | protein prenylation (GO:0018342) | 2.53537578 |
| 133 | prenylation (GO:0097354) | 2.53537578 |
| 134 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.53467829 |
| 135 | cellular response to zinc ion (GO:0071294) | 2.52781406 |
| 136 | histone H3-K4 trimethylation (GO:0080182) | 2.52545736 |
| 137 | aromatic amino acid family metabolic process (GO:0009072) | 2.51499953 |
| 138 | rRNA catabolic process (GO:0016075) | 2.50842844 |
| 139 | drug catabolic process (GO:0042737) | 2.50811431 |
| 140 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.50633036 |
| 141 | axoneme assembly (GO:0035082) | 2.50163306 |
| 142 | endosome to melanosome transport (GO:0035646) | 2.49852223 |
| 143 | endosome to pigment granule transport (GO:0043485) | 2.49852223 |
| 144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.48627190 |
| 145 | protein carboxylation (GO:0018214) | 2.48428306 |
| 146 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48428306 |
| 147 | T-helper 1 type immune response (GO:0042088) | 2.48287604 |
| 148 | cilium organization (GO:0044782) | 2.48146457 |
| 149 | apoptotic cell clearance (GO:0043277) | 2.48053246 |
| 150 | neuronal action potential (GO:0019228) | 2.47987910 |
| 151 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.47676198 |
| 152 | behavioral response to ethanol (GO:0048149) | 2.47366670 |
| 153 | response to interferon-beta (GO:0035456) | 2.46426465 |
| 154 | protein targeting to Golgi (GO:0000042) | 2.46017431 |
| 155 | cilium morphogenesis (GO:0060271) | 2.45978034 |
| 156 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.45522148 |
| 157 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.45502134 |
| 158 | cilium assembly (GO:0042384) | 2.44793959 |
| 159 | cilium movement (GO:0003341) | 2.43718804 |
| 160 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.43418430 |
| 161 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.43418430 |
| 162 | retinal cone cell development (GO:0046549) | 2.43093508 |
| 163 | cell adhesion mediated by integrin (GO:0033627) | 2.42971941 |
| 164 | limb development (GO:0060173) | 2.42838731 |
| 165 | appendage development (GO:0048736) | 2.42838731 |
| 166 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.42330521 |
| 167 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.42151575 |
| 168 | response to sterol (GO:0036314) | 2.39364177 |
| 169 | negative regulation of interleukin-12 production (GO:0032695) | 2.38478400 |
| 170 | I-kappaB phosphorylation (GO:0007252) | 2.38278243 |
| 171 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.37947262 |
| 172 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.37836943 |
| 173 | regulation of interferon-beta production (GO:0032648) | 2.37777726 |
| 174 | positive regulation of B cell differentiation (GO:0045579) | 2.37287377 |
| 175 | defense response to protozoan (GO:0042832) | 2.35510797 |
| 176 | cellular response to interferon-alpha (GO:0035457) | 2.35389217 |
| 177 | myeloid dendritic cell differentiation (GO:0043011) | 2.34083876 |
| 178 | macrophage activation (GO:0042116) | 2.33892433 |
| 179 | plasma lipoprotein particle clearance (GO:0034381) | 2.33445187 |
| 180 | leukocyte mediated cytotoxicity (GO:0001909) | 2.32419566 |
| 181 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.32228475 |
| 182 | positive regulation of chemokine production (GO:0032722) | 2.31851880 |
| 183 | positive regulation of mast cell activation (GO:0033005) | 2.31813673 |
| 184 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29952258 |
| 185 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.29535066 |
| 186 | neutrophil mediated immunity (GO:0002446) | 2.29491566 |
| 187 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.28810351 |
| 188 | cytokine secretion (GO:0050663) | 2.28527506 |
| 189 | microglial cell activation (GO:0001774) | 2.28019331 |
| 190 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.27161675 |
| 191 | positive regulation of antigen processing and presentation (GO:0002579) | 2.26907669 |
| 192 | response to protozoan (GO:0001562) | 2.26731186 |
| 193 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26502202 |
| 194 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26262204 |
| 195 | negative regulation of viral genome replication (GO:0045071) | 2.25695979 |
| 196 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.25219524 |
| 197 | cellular response to virus (GO:0098586) | 2.24587136 |
| 198 | positive regulation of heat generation (GO:0031652) | 2.23375402 |
| 199 | NIK/NF-kappaB signaling (GO:0038061) | 2.22904824 |
| 200 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.22761147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.51189877 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.45381458 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.35211249 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.28864271 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19353619 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02638722 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.94764898 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92057522 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90260738 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90106311 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76607537 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.76541337 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74096414 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.71582689 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66893239 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63232692 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.62947826 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.60056646 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.51460420 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.51145978 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.47407459 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46332548 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.46220102 |
| 24 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.44938001 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41232205 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35095570 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.25999558 |
| 28 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.21972632 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.19572370 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18465410 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17671517 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.16003183 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.15382072 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12751817 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.11220087 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.11160488 |
| 37 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.07521257 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.07318186 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05897995 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04894353 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01477195 |
| 42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99018520 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95176742 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.95152711 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.92300006 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.90958163 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89301577 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89158004 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.88629090 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.87311469 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87013847 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86273537 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86099728 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85072470 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.84707295 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83520484 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82079110 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81447485 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80860747 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79423171 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74937674 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74633742 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72313939 |
| 64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.72045065 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68029695 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67248043 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.65417348 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65351355 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65176554 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.64037663 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62928018 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60427337 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60406951 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.60285263 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59521544 |
| 76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58987075 |
| 77 | MYB_26560356_Chip-Seq_TH2_Human | 1.58157255 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55653968 |
| 79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.55154885 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55154885 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53545955 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52233337 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52177077 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.50730555 |
| 85 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48889059 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48889059 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48824585 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46599227 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.46390382 |
| 90 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45279185 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45263565 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44378300 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42997483 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41667734 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40030184 |
| 96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39471196 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39205157 |
| 98 | MYB_26560356_Chip-Seq_TH1_Human | 1.38821330 |
| 99 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38684005 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38672582 |
| 101 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38189613 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38065563 |
| 103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37582449 |
| 104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37429607 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36498333 |
| 106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35966102 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.34847047 |
| 108 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33356747 |
| 109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.33055720 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32979832 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32320785 |
| 112 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31408784 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31262292 |
| 114 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.31184725 |
| 115 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30363549 |
| 116 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29941427 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29527016 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29361018 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28650409 |
| 120 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28638602 |
| 121 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28465779 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25404558 |
| 123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25366040 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25205327 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24394950 |
| 126 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24381898 |
| 127 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23761240 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23612799 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21752239 |
| 130 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21489414 |
| 131 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21381589 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19343667 |
| 133 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18913213 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18575544 |
| 135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18442494 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16321554 |
| 137 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14834604 |
| 138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14240391 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14233270 |
| 140 | KDM2B_26808549_Chip-Seq_REH_Human | 1.13117822 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12948552 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11925616 |
| 143 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11720228 |
| 144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11677688 |
| 145 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11597707 |
| 146 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11027326 |
| 147 | MYC_22102868_ChIP-Seq_BL_Human | 1.11002339 |
| 148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10960769 |
| 149 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10861474 |
| 150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10790514 |
| 151 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10661423 |
| 152 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10303588 |
| 153 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09866056 |
| 154 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09667273 |
| 155 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09152856 |
| 156 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08561434 |
| 157 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08022960 |
| 158 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07917475 |
| 159 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07546161 |
| 160 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07250489 |
| 161 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07250489 |
| 162 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07100457 |
| 163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07100457 |
| 164 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05738874 |
| 165 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05637360 |
| 166 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03289843 |
| 167 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03261527 |
| 168 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02979654 |
| 169 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.02759109 |
| 170 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02645357 |
| 171 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02318893 |
| 172 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02281152 |
| 173 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02017620 |
| 174 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01148694 |
| 175 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01068544 |
| 176 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00218031 |
| 177 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99881353 |
| 178 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98943528 |
| 179 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97555541 |
| 180 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96809583 |
| 181 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95890544 |
| 182 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94610423 |
| 183 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94010158 |
| 184 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93503423 |
| 185 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92244076 |
| 186 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91778032 |
| 187 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89518535 |
| 188 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89518535 |
| 189 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89485436 |
| 190 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89014282 |
| 191 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88331942 |
| 192 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87988150 |
| 193 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87837414 |
| 194 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87611168 |
| 195 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87543083 |
| 196 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86771436 |
| 197 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85665149 |
| 198 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84087891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.50967198 |
| 2 | MP0008057_abnormal_DNA_replication | 3.99431663 |
| 3 | MP0004043_abnormal_pH_regulation | 3.15385815 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.14433829 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.06854055 |
| 6 | MP0003436_decreased_susceptibility_to | 3.05685504 |
| 7 | MP0001501_abnormal_sleep_pattern | 2.59095070 |
| 8 | MP0003646_muscle_fatigue | 2.55953722 |
| 9 | MP0009785_altered_susceptibility_to | 2.55454505 |
| 10 | MP0000427_abnormal_hair_cycle | 2.46790694 |
| 11 | MP0006082_CNS_inflammation | 2.44593003 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.42329801 |
| 13 | MP0002419_abnormal_innate_immunity | 2.39121972 |
| 14 | MP0009840_abnormal_foam_cell | 2.37609284 |
| 15 | MP0003303_peritoneal_inflammation | 2.35180243 |
| 16 | MP0009046_muscle_twitch | 2.29559987 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.22299479 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.21982102 |
| 19 | MP0003724_increased_susceptibility_to | 2.21260133 |
| 20 | MP0005025_abnormal_response_to | 2.14521196 |
| 21 | MP0000685_abnormal_immune_system | 2.11476988 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.06757894 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.05239802 |
| 24 | MP0000383_abnormal_hair_follicle | 2.02085265 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.99294721 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.98954969 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.98479993 |
| 28 | MP0003136_yellow_coat_color | 1.96953730 |
| 29 | MP0003045_fibrosis | 1.94652136 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.90681199 |
| 31 | MP0005387_immune_system_phenotype | 1.89802793 |
| 32 | MP0001790_abnormal_immune_system | 1.89802793 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.89709215 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.85542865 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.84750223 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.83370341 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.81594390 |
| 38 | MP0001800_abnormal_humoral_immune | 1.79914154 |
| 39 | MP0004947_skin_inflammation | 1.79177986 |
| 40 | MP0002723_abnormal_immune_serum | 1.74643196 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.73727345 |
| 42 | MP0005671_abnormal_response_to | 1.72752963 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.70544441 |
| 44 | MP0005253_abnormal_eye_physiology | 1.66305463 |
| 45 | MP0009745_abnormal_behavioral_response | 1.65157868 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.62488419 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.61825972 |
| 48 | MP0001853_heart_inflammation | 1.61488470 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.59868343 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.59046572 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.58878040 |
| 52 | MP0001819_abnormal_immune_cell | 1.58334747 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.57221508 |
| 54 | MP0000343_altered_response_to | 1.56601523 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.56473784 |
| 56 | MP0003186_abnormal_redox_activity | 1.55943912 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.55921891 |
| 58 | MP0005360_urolithiasis | 1.54268019 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.53731234 |
| 60 | MP0002006_tumorigenesis | 1.53370079 |
| 61 | MP0002928_abnormal_bile_duct | 1.52047194 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.51753300 |
| 63 | MP0004142_abnormal_muscle_tone | 1.51347024 |
| 64 | MP0005171_absent_coat_pigmentation | 1.51133826 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.51014793 |
| 66 | MP0002102_abnormal_ear_morphology | 1.50724022 |
| 67 | MP0008469_abnormal_protein_level | 1.50136874 |
| 68 | MP0009764_decreased_sensitivity_to | 1.49831693 |
| 69 | MP0002168_other_aberrant_phenotype | 1.49213700 |
| 70 | MP0002405_respiratory_system_inflammati | 1.48276992 |
| 71 | MP0004130_abnormal_muscle_cell | 1.46584611 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.44845229 |
| 73 | MP0003448_altered_tumor_morphology | 1.44268353 |
| 74 | MP0008872_abnormal_physiological_respon | 1.42523464 |
| 75 | MP0004924_abnormal_behavior | 1.42470608 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.42470608 |
| 77 | MP0000858_altered_metastatic_potential | 1.42247420 |
| 78 | MP0005083_abnormal_biliary_tract | 1.41747985 |
| 79 | MP0003787_abnormal_imprinting | 1.40894720 |
| 80 | MP0000538_abnormal_urinary_bladder | 1.39244674 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.39190119 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 1.37083289 |
| 83 | MP0010307_abnormal_tumor_latency | 1.36351924 |
| 84 | MP0002736_abnormal_nociception_after | 1.36287007 |
| 85 | MP0001485_abnormal_pinna_reflex | 1.36224354 |
| 86 | MP0005023_abnormal_wound_healing | 1.36052574 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.34738132 |
| 88 | MP0003195_calcinosis | 1.30479685 |
| 89 | MP0006054_spinal_hemorrhage | 1.29747818 |
| 90 | MP0004147_increased_porphyrin_level | 1.28425726 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 1.28096111 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.27509180 |
| 93 | MP0001545_abnormal_hematopoietic_system | 1.27509180 |
| 94 | MP0002998_abnormal_bone_remodeling | 1.27023193 |
| 95 | MP0009278_abnormal_bone_marrow | 1.25832344 |
| 96 | MP0001486_abnormal_startle_reflex | 1.23408329 |
| 97 | MP0002064_seizures | 1.23400210 |
| 98 | MP0002638_abnormal_pupillary_reflex | 1.22136204 |
| 99 | MP0000372_irregular_coat_pigmentation | 1.21274465 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.21159865 |
| 101 | MP0000716_abnormal_immune_system | 1.20642029 |
| 102 | MP0002254_reproductive_system_inflammat | 1.20013765 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 1.18666165 |
| 104 | MP0005365_abnormal_bile_salt | 1.18426610 |
| 105 | MP0005187_abnormal_penis_morphology | 1.18000973 |
| 106 | MP0000230_abnormal_systemic_arterial | 1.16355929 |
| 107 | MP0002398_abnormal_bone_marrow | 1.16254576 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 1.15838686 |
| 109 | MP0005275_abnormal_skin_tensile | 1.15147793 |
| 110 | MP0002272_abnormal_nervous_system | 1.14812849 |
| 111 | MP0009763_increased_sensitivity_to | 1.14160749 |
| 112 | MP0003075_altered_response_to | 1.13635035 |
| 113 | MP0002067_abnormal_sensory_capabilities | 1.12522162 |
| 114 | MP0000689_abnormal_spleen_morphology | 1.11265857 |
| 115 | MP0002572_abnormal_emotion/affect_behav | 1.09369615 |
| 116 | MP0000609_abnormal_liver_physiology | 1.08044263 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 1.07245868 |
| 118 | MP0004510_myositis | 1.06009042 |
| 119 | MP0002557_abnormal_social/conspecific_i | 1.05812164 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 1.05320466 |
| 121 | MP0002429_abnormal_blood_cell | 1.05258857 |
| 122 | MP0001958_emphysema | 1.05233420 |
| 123 | MP0002938_white_spotting | 1.04358675 |
| 124 | MP0003279_aneurysm | 1.04098448 |
| 125 | MP0002095_abnormal_skin_pigmentation | 1.03870700 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 1.03845786 |
| 127 | MP0002138_abnormal_hepatobiliary_system | 1.03219614 |
| 128 | MP0002396_abnormal_hematopoietic_system | 1.02751059 |
| 129 | MP0003633_abnormal_nervous_system | 1.02624847 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 1.01624412 |
| 131 | MP0002722_abnormal_immune_system | 1.00762925 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 1.00604384 |
| 133 | MP0005266_abnormal_metabolism | 1.00284958 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 1.00237488 |
| 135 | MP0002009_preneoplasia | 1.00014431 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.99780105 |
| 137 | MP0000604_amyloidosis | 0.99598817 |
| 138 | MP0001970_abnormal_pain_threshold | 0.97044187 |
| 139 | MP0005164_abnormal_response_to | 0.96911827 |
| 140 | MP0002933_joint_inflammation | 0.96647133 |
| 141 | MP0005076_abnormal_cell_differentiation | 0.96596187 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.96500276 |
| 143 | MP0005395_other_phenotype | 0.94361743 |
| 144 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93625310 |
| 145 | MP0000631_abnormal_neuroendocrine_gland | 0.92695040 |
| 146 | MP0002733_abnormal_thermal_nociception | 0.92100424 |
| 147 | MP0005390_skeleton_phenotype | 0.91719941 |
| 148 | MP0005670_abnormal_white_adipose | 0.91685842 |
| 149 | MP0003252_abnormal_bile_duct | 0.90139421 |
| 150 | MP0004215_abnormal_myocardial_fiber | 0.89659784 |
| 151 | MP0000598_abnormal_liver_morphology | 0.89652256 |
| 152 | MP0002653_abnormal_ependyma_morphology | 0.88601059 |
| 153 | MP0004808_abnormal_hematopoietic_stem | 0.87817888 |
| 154 | MP0010329_abnormal_lipoprotein_level | 0.87744110 |
| 155 | MP0005377_hearing/vestibular/ear_phenot | 0.87193235 |
| 156 | MP0003878_abnormal_ear_physiology | 0.87193235 |
| 157 | MP0005166_decreased_susceptibility_to | 0.87179948 |
| 158 | MP0009643_abnormal_urine_homeostasis | 0.86087247 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.85871021 |
| 160 | MP0000015_abnormal_ear_pigmentation | 0.84906755 |
| 161 | MP0002229_neurodegeneration | 0.83660061 |
| 162 | MP0001851_eye_inflammation | 0.83522529 |
| 163 | MP0003795_abnormal_bone_structure | 0.83119128 |
| 164 | MP0005647_abnormal_sex_gland | 0.83052186 |
| 165 | MP0000249_abnormal_blood_vessel | 0.82453253 |
| 166 | MP0005195_abnormal_posterior_eye | 0.82264921 |
| 167 | MP0005167_abnormal_blood-brain_barrier | 0.81108004 |
| 168 | MP0003631_nervous_system_phenotype | 0.80521428 |
| 169 | MP0000470_abnormal_stomach_morphology | 0.80494957 |
| 170 | MP0005310_abnormal_salivary_gland | 0.79516723 |
| 171 | MP0003635_abnormal_synaptic_transmissio | 0.79008504 |
| 172 | MP0001984_abnormal_olfaction | 0.78657353 |
| 173 | MP0001756_abnormal_urination | 0.78579006 |
| 174 | MP0002063_abnormal_learning/memory/cond | 0.77807553 |
| 175 | MP0002136_abnormal_kidney_physiology | 0.77578387 |
| 176 | MP0000371_diluted_coat_color | 0.77349081 |
| 177 | MP0005448_abnormal_energy_balance | 0.77195373 |
| 178 | MP0001324_abnormal_eye_pigmentation | 0.76763300 |
| 179 | MP0003632_abnormal_nervous_system | 0.75587309 |
| 180 | MP0005389_reproductive_system_phenotype | 0.75249335 |
| 181 | MP0009115_abnormal_fat_cell | 0.75130408 |
| 182 | MP0001666_abnormal_nutrient_absorption | 0.74118118 |
| 183 | MP0001915_intracranial_hemorrhage | 0.74065770 |
| 184 | MP0004381_abnormal_hair_follicle | 0.72767265 |
| 185 | MP0001664_abnormal_digestion | 0.72577985 |
| 186 | MP0005075_abnormal_melanosome_morpholog | 0.71943148 |
| 187 | MP0004133_heterotaxia | 0.70332870 |
| 188 | MP0004742_abnormal_vestibular_system | 0.69014079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 5.20948636 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.07102262 |
| 3 | Hyperventilation (HP:0002883) | 5.05697293 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.85776944 |
| 5 | Pancreatic cysts (HP:0001737) | 4.73868780 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.71725991 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.43121536 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.34141207 |
| 9 | Pancreatic fibrosis (HP:0100732) | 4.21775605 |
| 10 | Gaze-evoked nystagmus (HP:0000640) | 4.20043893 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.99818320 |
| 12 | True hermaphroditism (HP:0010459) | 3.98906188 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.87781715 |
| 14 | Protruding tongue (HP:0010808) | 3.75687559 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.70619370 |
| 16 | * Increased cerebral lipofuscin (HP:0011813) | 3.69067902 |
| 17 | Congenital stationary night blindness (HP:0007642) | 3.65732864 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.62299112 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.62299112 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58461038 |
| 21 | Fair hair (HP:0002286) | 3.51406623 |
| 22 | Abnormality of the renal cortex (HP:0011035) | 3.48541131 |
| 23 | Chronic hepatic failure (HP:0100626) | 3.45096590 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.43531891 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 3.32642988 |
| 26 | * Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.28354912 |
| 27 | Nephronophthisis (HP:0000090) | 3.23171602 |
| 28 | Abnormality of the renal medulla (HP:0100957) | 3.19652695 |
| 29 | Myocardial infarction (HP:0001658) | 3.16701199 |
| 30 | Recurrent skin infections (HP:0001581) | 3.16226469 |
| 31 | Cystic liver disease (HP:0006706) | 3.15686153 |
| 32 | Myositis (HP:0100614) | 3.10988021 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.09443926 |
| 34 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04212539 |
| 35 | Mucopolysacchariduria (HP:0008155) | 3.04212539 |
| 36 | Axonal loss (HP:0003447) | 3.04055018 |
| 37 | Febrile seizures (HP:0002373) | 2.96976531 |
| 38 | Congenital sensorineural hearing impairment (HP:0008527) | 2.93504098 |
| 39 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.93443159 |
| 40 | Tubular atrophy (HP:0000092) | 2.90171704 |
| 41 | Hematochezia (HP:0002573) | 2.87805457 |
| 42 | Orchitis (HP:0100796) | 2.84297768 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.81357634 |
| 44 | Generalized hypopigmentation of hair (HP:0011358) | 2.80348536 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77481089 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77481089 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77481089 |
| 48 | Absent speech (HP:0001344) | 2.74121147 |
| 49 | Gingivitis (HP:0000230) | 2.73334162 |
| 50 | Glomerulonephritis (HP:0000099) | 2.71831177 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.70312762 |
| 52 | Tetraparesis (HP:0002273) | 2.69620796 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.69401335 |
| 54 | Decreased circulating renin level (HP:0003351) | 2.68969038 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.68810992 |
| 56 | Broad-based gait (HP:0002136) | 2.62186980 |
| 57 | Peritonitis (HP:0002586) | 2.61327739 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.56761694 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.56761694 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.56761694 |
| 61 | Abnormal drinking behavior (HP:0030082) | 2.50724490 |
| 62 | Polydipsia (HP:0001959) | 2.50724490 |
| 63 | Gingival bleeding (HP:0000225) | 2.50366400 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.49171796 |
| 65 | Abolished electroretinogram (ERG) (HP:0000550) | 2.48608781 |
| 66 | Urticaria (HP:0001025) | 2.48520985 |
| 67 | Widely spaced teeth (HP:0000687) | 2.48278193 |
| 68 | Recurrent viral infections (HP:0004429) | 2.45509971 |
| 69 | Complement deficiency (HP:0004431) | 2.44767186 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 2.44609540 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.44609540 |
| 72 | Congenital hepatic fibrosis (HP:0002612) | 2.44376148 |
| 73 | Large for gestational age (HP:0001520) | 2.43460049 |
| 74 | Xanthomatosis (HP:0000991) | 2.42483339 |
| 75 | Pustule (HP:0200039) | 2.41749229 |
| 76 | Periodontitis (HP:0000704) | 2.38492225 |
| 77 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.38140526 |
| 78 | Vasculitis (HP:0002633) | 2.36298316 |
| 79 | Furrowed tongue (HP:0000221) | 2.35768500 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.34806558 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.34806558 |
| 82 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.34009914 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.30504852 |
| 84 | Disinhibition (HP:0000734) | 2.29799885 |
| 85 | Dialeptic seizures (HP:0011146) | 2.27801649 |
| 86 | Inability to walk (HP:0002540) | 2.27467355 |
| 87 | Thrombocytosis (HP:0001894) | 2.27227468 |
| 88 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26730628 |
| 89 | Cellulitis (HP:0100658) | 2.25122023 |
| 90 | Increased serum ferritin (HP:0003281) | 2.23849678 |
| 91 | Chronic otitis media (HP:0000389) | 2.23832259 |
| 92 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.23807998 |
| 93 | Petechiae (HP:0000967) | 2.22954450 |
| 94 | Gait imbalance (HP:0002141) | 2.22738263 |
| 95 | Stomatitis (HP:0010280) | 2.22261449 |
| 96 | Renal cortical cysts (HP:0000803) | 2.22226264 |
| 97 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.22083662 |
| 98 | Absent/shortened dynein arms (HP:0200106) | 2.22083662 |
| 99 | Joint hemorrhage (HP:0005261) | 2.21713774 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 2.21640202 |
| 101 | Optic neuritis (HP:0100653) | 2.21640202 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.21564467 |
| 103 | Abnormality of complement system (HP:0005339) | 2.21561171 |
| 104 | Cervical subluxation (HP:0003308) | 2.21174009 |
| 105 | Hypoplastic labia majora (HP:0000059) | 2.21146409 |
| 106 | Type II lissencephaly (HP:0007260) | 2.20570096 |
| 107 | Congenital primary aphakia (HP:0007707) | 2.19615560 |
| 108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18905425 |
| 109 | Abnormality of alanine metabolism (HP:0010916) | 2.18905425 |
| 110 | Hyperalaninemia (HP:0003348) | 2.18905425 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18108768 |
| 112 | Obstructive lung disease (HP:0006536) | 2.18108768 |
| 113 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.18052225 |
| 114 | Nausea (HP:0002018) | 2.16456601 |
| 115 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16023760 |
| 116 | Progressive inability to walk (HP:0002505) | 2.15880464 |
| 117 | Pathologic fracture (HP:0002756) | 2.15149207 |
| 118 | Absence seizures (HP:0002121) | 2.15114009 |
| 119 | Keratoconus (HP:0000563) | 2.14875554 |
| 120 | Increased corneal curvature (HP:0100692) | 2.14875554 |
| 121 | Abnormality of the labia majora (HP:0012881) | 2.14681151 |
| 122 | Cerebellar dysplasia (HP:0007033) | 2.14540028 |
| 123 | Central scotoma (HP:0000603) | 2.13244749 |
| 124 | Patellar aplasia (HP:0006443) | 2.13119765 |
| 125 | Arterial thrombosis (HP:0004420) | 2.12461263 |
| 126 | Nephritis (HP:0000123) | 2.11692788 |
| 127 | Osteomyelitis (HP:0002754) | 2.10545966 |
| 128 | Esophageal varix (HP:0002040) | 2.10533131 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09554344 |
| 130 | Loss of speech (HP:0002371) | 2.08489859 |
| 131 | Dysmetric saccades (HP:0000641) | 2.06677375 |
| 132 | Spontaneous hematomas (HP:0007420) | 2.05864133 |
| 133 | Hypoplastic ischia (HP:0003175) | 2.05862471 |
| 134 | Hepatosplenomegaly (HP:0001433) | 2.05587592 |
| 135 | Stomach cancer (HP:0012126) | 2.05238886 |
| 136 | Preaxial foot polydactyly (HP:0001841) | 2.04727747 |
| 137 | Postaxial foot polydactyly (HP:0001830) | 2.04684295 |
| 138 | Decreased central vision (HP:0007663) | 2.03032461 |
| 139 | Focal seizures (HP:0007359) | 2.01843878 |
| 140 | Birth length less than 3rd percentile (HP:0003561) | 2.01024292 |
| 141 | Abnormal biliary tract physiology (HP:0012439) | 2.00262013 |
| 142 | Bile duct proliferation (HP:0001408) | 2.00262013 |
| 143 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99019476 |
| 144 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99019476 |
| 145 | Agnosia (HP:0010524) | 1.98379842 |
| 146 | Deep venous thrombosis (HP:0002625) | 1.98226936 |
| 147 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98103308 |
| 148 | Abnormality of the ischium (HP:0003174) | 1.98018529 |
| 149 | Genital tract atresia (HP:0001827) | 1.97584701 |
| 150 | Leukocytosis (HP:0001974) | 1.97576323 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96939541 |
| 152 | Epistaxis (HP:0000421) | 1.96173305 |
| 153 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95834083 |
| 154 | Purpura (HP:0000979) | 1.94711365 |
| 155 | Poor head control (HP:0002421) | 1.94591336 |
| 156 | Diplopia (HP:0000651) | 1.93712029 |
| 157 | Abnormality of binocular vision (HP:0011514) | 1.93712029 |
| 158 | Facial diplegia (HP:0001349) | 1.93404793 |
| 159 | Sclerocornea (HP:0000647) | 1.93030243 |
| 160 | Abnormal ciliary motility (HP:0012262) | 1.91389669 |
| 161 | Beaking of vertebral bodies (HP:0004568) | 1.90823848 |
| 162 | Spondylolisthesis (HP:0003302) | 1.90688712 |
| 163 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.90663846 |
| 164 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.90302617 |
| 165 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.90302617 |
| 166 | Male pseudohermaphroditism (HP:0000037) | 1.89993113 |
| 167 | Vaginal atresia (HP:0000148) | 1.88861052 |
| 168 | Anencephaly (HP:0002323) | 1.88369034 |
| 169 | Conjunctival telangiectasia (HP:0000524) | 1.88069652 |
| 170 | Short foot (HP:0001773) | 1.87152349 |
| 171 | Chorioretinal atrophy (HP:0000533) | 1.87110881 |
| 172 | Intrahepatic cholestasis (HP:0001406) | 1.87038527 |
| 173 | Abnormality of the lumbar spine (HP:0100712) | 1.85687849 |
| 174 | Poor coordination (HP:0002370) | 1.85323050 |
| 175 | Blue irides (HP:0000635) | 1.85075710 |
| 176 | * Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84689238 |
| 177 | Pulmonary infiltrates (HP:0002113) | 1.82994940 |
| 178 | Polyuria (HP:0000103) | 1.82396584 |
| 179 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.81346415 |
| 180 | Protrusio acetabuli (HP:0003179) | 1.80829846 |
| 181 | Thyroiditis (HP:0100646) | 1.79903910 |
| 182 | Highly arched eyebrow (HP:0002553) | 1.79337554 |
| 183 | Asymmetric septal hypertrophy (HP:0001670) | 1.79132130 |
| 184 | Bulbous nose (HP:0000414) | 1.78972938 |
| 185 | Thrombophlebitis (HP:0004418) | 1.78706385 |
| 186 | Atonic seizures (HP:0010819) | 1.77382254 |
| 187 | Thoracic kyphosis (HP:0002942) | 1.77277905 |
| 188 | Anorexia (HP:0002039) | 1.76908306 |
| 189 | Drooling (HP:0002307) | 1.75439564 |
| 190 | Hypergammaglobulinemia (HP:0010702) | 1.74485225 |
| 191 | Abnormal platelet volume (HP:0011876) | 1.74467890 |
| 192 | Hypoplasia of the pons (HP:0012110) | 1.72506486 |
| 193 | Abnormality of the pons (HP:0007361) | 1.72445523 |
| 194 | Hemiparesis (HP:0001269) | 1.71711040 |
| 195 | Small hand (HP:0200055) | 1.71471945 |
| 196 | Abnormality of macular pigmentation (HP:0008002) | 1.71044631 |
| 197 | Tented upper lip vermilion (HP:0010804) | 1.70924295 |
| 198 | Macroglossia (HP:0000158) | 1.70801874 |
| 199 | Hyperkalemia (HP:0002153) | 1.70542497 |
| 200 | Enlarged kidneys (HP:0000105) | 1.70523011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.87557257 |
| 2 | ERN1 | 3.49030052 |
| 3 | BMPR1B | 3.35983978 |
| 4 | TYK2 | 3.16463469 |
| 5 | TBK1 | 2.95600006 |
| 6 | MAP3K14 | 2.86163062 |
| 7 | BLK | 2.57411176 |
| 8 | PIM2 | 2.30444431 |
| 9 | KIT | 2.29370078 |
| 10 | ADRBK2 | 2.26046007 |
| 11 | AKT3 | 2.20746524 |
| 12 | MAP4K1 | 2.10891760 |
| 13 | NME2 | 2.09431132 |
| 14 | IRAK3 | 2.06955689 |
| 15 | JAK3 | 2.04830365 |
| 16 | INSRR | 2.03758752 |
| 17 | IRAK4 | 2.02142109 |
| 18 | CASK | 1.96034474 |
| 19 | IKBKE | 1.95415831 |
| 20 | MAP2K3 | 1.85613317 |
| 21 | IKBKB | 1.84329117 |
| 22 | SCYL2 | 1.84052983 |
| 23 | NEK9 | 1.83717994 |
| 24 | MKNK2 | 1.83700369 |
| 25 | RIPK4 | 1.83317189 |
| 26 | JAK1 | 1.81733540 |
| 27 | TGFBR2 | 1.74963041 |
| 28 | FGFR4 | 1.74917112 |
| 29 | ZAP70 | 1.73308074 |
| 30 | FLT3 | 1.70410045 |
| 31 | STK10 | 1.67329138 |
| 32 | TRIB3 | 1.61240098 |
| 33 | LRRK2 | 1.59655288 |
| 34 | PBK | 1.58880612 |
| 35 | OXSR1 | 1.56401650 |
| 36 | RPS6KA4 | 1.55930743 |
| 37 | MAPK13 | 1.54797012 |
| 38 | GRK1 | 1.53787845 |
| 39 | WNK3 | 1.52766882 |
| 40 | PIK3CG | 1.43554871 |
| 41 | STK39 | 1.39506354 |
| 42 | ZAK | 1.38973118 |
| 43 | CSF1R | 1.37315520 |
| 44 | PKN2 | 1.37242371 |
| 45 | EPHB1 | 1.36141449 |
| 46 | KDR | 1.34815564 |
| 47 | STK38L | 1.34154859 |
| 48 | TAOK3 | 1.30306587 |
| 49 | NTRK3 | 1.29707755 |
| 50 | NUAK1 | 1.28291293 |
| 51 | MAP3K3 | 1.25789035 |
| 52 | ADRBK1 | 1.25456475 |
| 53 | CSK | 1.19896651 |
| 54 | SIK1 | 1.19641701 |
| 55 | CHUK | 1.18938718 |
| 56 | TXK | 1.18815453 |
| 57 | WNK4 | 1.15596892 |
| 58 | PIM1 | 1.15303012 |
| 59 | BTK | 1.10685468 |
| 60 | TGFBR1 | 1.10274324 |
| 61 | BRSK2 | 1.09164561 |
| 62 | TTN | 1.07742184 |
| 63 | TEC | 1.06821803 |
| 64 | DAPK2 | 1.05865205 |
| 65 | MAP3K4 | 1.05483712 |
| 66 | BCKDK | 1.05372130 |
| 67 | SGK2 | 1.05304532 |
| 68 | MAP3K11 | 1.04127858 |
| 69 | FGFR3 | 1.02983401 |
| 70 | MATK | 1.02127607 |
| 71 | JAK2 | 0.99916684 |
| 72 | TRPM7 | 0.99278336 |
| 73 | PTK6 | 0.96680906 |
| 74 | CAMK1G | 0.96419158 |
| 75 | FER | 0.95682410 |
| 76 | TLK1 | 0.94776049 |
| 77 | PTK2B | 0.94103964 |
| 78 | PINK1 | 0.93640895 |
| 79 | MELK | 0.92478079 |
| 80 | ABL2 | 0.92117832 |
| 81 | BRD4 | 0.91905435 |
| 82 | CDK6 | 0.91757987 |
| 83 | BMX | 0.90877498 |
| 84 | MAP4K2 | 0.89849800 |
| 85 | MAP3K10 | 0.89679739 |
| 86 | LATS1 | 0.88367226 |
| 87 | LCK | 0.88223494 |
| 88 | PAK3 | 0.87734168 |
| 89 | EIF2AK3 | 0.84407382 |
| 90 | SYK | 0.82889644 |
| 91 | ACVR1B | 0.82254649 |
| 92 | LYN | 0.81967685 |
| 93 | PRKAA2 | 0.81247852 |
| 94 | HCK | 0.80605301 |
| 95 | EPHA3 | 0.79766542 |
| 96 | TNIK | 0.79658227 |
| 97 | TNK2 | 0.78433866 |
| 98 | MAP3K13 | 0.78051251 |
| 99 | STK4 | 0.77931067 |
| 100 | PRKCE | 0.75120510 |
| 101 | PAK4 | 0.74445798 |
| 102 | MAP3K7 | 0.73740487 |
| 103 | TESK1 | 0.73439792 |
| 104 | MST1R | 0.73349458 |
| 105 | PIK3CA | 0.72855521 |
| 106 | MARK3 | 0.72179833 |
| 107 | RIPK1 | 0.71488643 |
| 108 | MAP3K8 | 0.66963888 |
| 109 | ITK | 0.64747726 |
| 110 | STK3 | 0.64086581 |
| 111 | CDK12 | 0.63792469 |
| 112 | STK38 | 0.63121558 |
| 113 | EGFR | 0.60650559 |
| 114 | MAP3K5 | 0.60306966 |
| 115 | PNCK | 0.58557923 |
| 116 | MAP2K6 | 0.57716351 |
| 117 | MKNK1 | 0.57175664 |
| 118 | TAOK2 | 0.57147084 |
| 119 | SGK223 | 0.56451668 |
| 120 | SGK494 | 0.56451668 |
| 121 | PRKG2 | 0.54541227 |
| 122 | CAMK4 | 0.54130363 |
| 123 | PRKCG | 0.54109731 |
| 124 | ABL1 | 0.53263407 |
| 125 | MST4 | 0.52830851 |
| 126 | PRKAA1 | 0.52348335 |
| 127 | FGFR2 | 0.50798536 |
| 128 | WNK1 | 0.50721647 |
| 129 | EIF2AK1 | 0.50250966 |
| 130 | CAMK1 | 0.47596957 |
| 131 | MET | 0.46835743 |
| 132 | CAMK2A | 0.46522899 |
| 133 | PRKCD | 0.45942738 |
| 134 | TESK2 | 0.45307888 |
| 135 | PKN1 | 0.45265553 |
| 136 | STK11 | 0.44574192 |
| 137 | ERBB2 | 0.43880138 |
| 138 | TIE1 | 0.43794790 |
| 139 | CAMK1D | 0.43317030 |
| 140 | MAPKAPK2 | 0.43184244 |
| 141 | SIK2 | 0.43137835 |
| 142 | MAPK15 | 0.42796691 |
| 143 | IRAK1 | 0.42592770 |
| 144 | OBSCN | 0.42528381 |
| 145 | PLK2 | 0.42423256 |
| 146 | MAPKAPK3 | 0.41843519 |
| 147 | MARK1 | 0.41194962 |
| 148 | MAP3K1 | 0.40564220 |
| 149 | EIF2AK2 | 0.39280372 |
| 150 | IGF1R | 0.39213248 |
| 151 | SGK3 | 0.38803032 |
| 152 | SGK1 | 0.38680374 |
| 153 | PDGFRA | 0.38099283 |
| 154 | PDGFRB | 0.37817043 |
| 155 | MAPK11 | 0.37808612 |
| 156 | GRK7 | 0.37768765 |
| 157 | ERBB4 | 0.35419293 |
| 158 | MUSK | 0.34838669 |
| 159 | PAK2 | 0.33206739 |
| 160 | MAP2K2 | 0.33022352 |
| 161 | CAMKK2 | 0.33003532 |
| 162 | GSK3A | 0.32972031 |
| 163 | PRKCQ | 0.32504012 |
| 164 | GRK6 | 0.32478638 |
| 165 | PRKCH | 0.32229633 |
| 166 | NLK | 0.32199215 |
| 167 | MAP2K1 | 0.32098827 |
| 168 | MAPKAPK5 | 0.29778207 |
| 169 | CSNK1D | 0.29247672 |
| 170 | PRKACA | 0.27179033 |
| 171 | PRKG1 | 0.26742569 |
| 172 | ERBB3 | 0.26551605 |
| 173 | BMPR2 | 0.26416743 |
| 174 | EPHA4 | 0.25262529 |
| 175 | RPS6KA6 | 0.24714911 |
| 176 | PRKACB | 0.24276180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.93866710 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80363265 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37222578 |
| 4 | * Lysosome_Homo sapiens_hsa04142 | 2.25320224 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.20614459 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.14391057 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.13921083 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.12750908 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09301962 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.07019513 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06200156 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.02437592 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.98914519 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.97483618 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95434506 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88705448 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.88640680 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82171026 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.80556778 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80227979 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.76265546 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.75156772 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.69688317 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.69577402 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.68543769 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62243779 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.61251190 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.60407889 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.59927924 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59566921 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58480779 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58304061 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56415300 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55540311 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.51027265 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50075447 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.45726829 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40167650 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39446504 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38079200 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36032156 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 1.34732387 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.33035360 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31527319 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.29112852 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.29027659 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.27824928 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.26545672 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25956578 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 1.24078973 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23344981 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22279159 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.21814614 |
| 54 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.21553226 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21356651 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20728222 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20344935 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19516610 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18985347 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18760708 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18732632 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17416172 |
| 63 | Asthma_Homo sapiens_hsa05310 | 1.16716391 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14666609 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13721049 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13185437 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10392144 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 1.10281120 |
| 69 | Salivary secretion_Homo sapiens_hsa04970 | 1.10081722 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09238310 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06953329 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05201649 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00686789 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 1.00607183 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00581203 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.98648494 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96596817 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93250218 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93130676 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92679618 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91326390 |
| 82 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90877433 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90199084 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.88688708 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88231774 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85842976 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85326213 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85150266 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84328394 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84059998 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83400542 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.82796803 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.82006050 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.81796246 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81520880 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78378935 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78221347 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76211595 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75998129 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75396179 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75270554 |
| 102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74417805 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74148553 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73989615 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73910883 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73753954 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73369807 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.73333891 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71960512 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71872575 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71261111 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.71223342 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71142012 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71099239 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70849538 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69709479 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.68578610 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68126826 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66690861 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66637218 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66234499 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64395575 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63060156 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61831927 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61003958 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60593197 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60335193 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59850168 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59762760 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58537288 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58396709 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57411291 |
| 133 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57386907 |
| 134 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57331532 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55957313 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54805923 |
| 137 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53909935 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53790649 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53533553 |
| 140 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52728265 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52581333 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52502069 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52431670 |
| 144 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52367160 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52028899 |
| 146 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51377291 |
| 147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51035490 |
| 148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50808695 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49233170 |
| 150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48593055 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.48467778 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.47938005 |
| 153 | ABC transporters_Homo sapiens_hsa02010 | 0.47864527 |
| 154 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47401972 |
| 155 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45531345 |
| 156 | Platelet activation_Homo sapiens_hsa04611 | 0.45380386 |
| 157 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44248197 |
| 158 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44026977 |
| 159 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44006714 |
| 160 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43566198 |
| 161 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43560882 |
| 162 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43177347 |
| 163 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41912764 |
| 164 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41792152 |
| 165 | Bile secretion_Homo sapiens_hsa04976 | 0.41472874 |
| 166 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40475490 |
| 167 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35875243 |
| 168 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35684360 |

